Industry: Chemical & Material
Published Date: 2026-03-11
Pages: 78 Pages
Report ld: 6184642
Request Sample
Customized Report
Metamizole Sodium API Market Size(US$)

CAGR 2026-2032
3.6%
Market Size,2032
USD 504
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Metamizole Sodium API market size was US$ 395 million in 2025 and is forecast to reach a readjusted size of US$ 504 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Metamizole Sodium API (also known as Dipyrone Sodium API) is the active ingredient used in the production of formulated medications for pain relief and fever reduction. It is the pure, unformulated compound that provides the therapeutic effects in oral tablets, injectable solutions, and other dosage forms. Metamizole is a non-opioid analgesic and antipyretic from the pyrazolone class of drugs.
In 2025, the North America Metamizole Sodium API market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Metamizole Sodium API include Arcadia Lifescience, Hengdian Group, Shandong Xinhua Pharmaceutical, Wuhan Wuyao Pharmaceutical, Astitva Chemicals, Chemcopia, Safic-Alcan, Naarini Molbio Pharma, Conscientia Industrial, Pipelinepharma, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Metamizole Sodium API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Metamizole Sodium API sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Metamizole Sodium API manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Metamizole Sodium API product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Metamizole Sodium API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Metamizole Sodium API Product Scope
1.2 Metamizole Sodium API by Type
1.2.1 Global Metamizole Sodium API Sales by Type (2021, 2025 & 2032)
1.2.2 More than 99%
1.2.3 Less than 99%
1.3 Metamizole Sodium API by Application
1.3.1 Global Metamizole Sodium API Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Global Metamizole Sodium API Market Estimates and Forecasts (2021-2032)
1.4.1 Global Metamizole Sodium API Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Metamizole Sodium API Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Metamizole Sodium API Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Metamizole Sodium API Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Metamizole Sodium API Historical Market Scenario by Region (2021-2026)
2.2.1 Global Metamizole Sodium API Sales Market Share by Region (2021-2026)
2.2.2 Global Metamizole Sodium API Revenue Market Share by Region (2021-2026)
2.3 Global Metamizole Sodium API Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Metamizole Sodium API Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Metamizole Sodium API Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Metamizole Sodium API Market Size and Prospects (2021-2032)
2.4.2 Europe Metamizole Sodium API Market Size and Prospects (2021-2032)
2.4.3 China Metamizole Sodium API Market Size and Prospects (2021-2032)
2.4.4 Japan Metamizole Sodium API Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Metamizole Sodium API Historical Market Review by Type (2021-2026)
3.1.1 Global Metamizole Sodium API Sales by Type (2021-2026)
3.1.2 Global Metamizole Sodium API Revenue by Type (2021-2026)
3.1.3 Global Metamizole Sodium API Average Price by Type (2021-2026)
3.2 Global Metamizole Sodium API Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Metamizole Sodium API Sales Forecast by Type (2027-2032)
3.2.2 Global Metamizole Sodium API Revenue Forecast by Type (2027-2032)
3.2.3 Global Metamizole Sodium API Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Metamizole Sodium API
4 Global Market Size by Application
4.1 Global Metamizole Sodium API Historical Market Review by Application (2021-2026)
4.1.1 Global Metamizole Sodium API Sales by Application (2021-2026)
4.1.2 Global Metamizole Sodium API Revenue by Application (2021-2026)
4.1.3 Global Metamizole Sodium API Average Price by Application (2021-2026)
4.2 Global Metamizole Sodium API Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Metamizole Sodium API Sales Forecast by Application (2027-2032)
4.2.2 Global Metamizole Sodium API Revenue Forecast by Application (2027-2032)
4.2.3 Global Metamizole Sodium API Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Metamizole Sodium API Applications
5 Competition Landscape by Players
5.1 Global Metamizole Sodium API Sales by Player (2021-2026)
5.2 Global Top Metamizole Sodium API Players by Revenue (2021-2026)
5.3 Global Metamizole Sodium API Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Metamizole Sodium API revenue as of 2025
5.4 Global Metamizole Sodium API Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Metamizole Sodium API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Metamizole Sodium API, Product Type & Application
5.7 Global Key Manufacturers of Metamizole Sodium API, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Metamizole Sodium API Sales by Company
6.1.1.1 North America Metamizole Sodium API Sales by Company (2021-2026)
6.1.1.2 North America Metamizole Sodium API Revenue by Company (2021-2026)
6.1.2 North America Metamizole Sodium API Sales Breakdown by Type (2021-2026)
6.1.3 North America Metamizole Sodium API Sales Breakdown by Application (2021-2026)
6.1.4 North America Metamizole Sodium API Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Metamizole Sodium API Sales by Company
6.2.1.1 Europe Metamizole Sodium API Sales by Company (2021-2026)
6.2.1.2 Europe Metamizole Sodium API Revenue by Company (2021-2026)
6.2.2 Europe Metamizole Sodium API Sales Breakdown by Type (2021-2026)
6.2.3 Europe Metamizole Sodium API Sales Breakdown by Application (2021-2026)
6.2.4 Europe Metamizole Sodium API Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Metamizole Sodium API Sales by Company
6.3.1.1 China Metamizole Sodium API Sales by Company (2021-2026)
6.3.1.2 China Metamizole Sodium API Revenue by Company (2021-2026)
6.3.2 China Metamizole Sodium API Sales Breakdown by Type (2021-2026)
6.3.3 China Metamizole Sodium API Sales Breakdown by Application (2021-2026)
6.3.4 China Metamizole Sodium API Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Metamizole Sodium API Sales by Company
6.4.1.1 Japan Metamizole Sodium API Sales by Company (2021-2026)
6.4.1.2 Japan Metamizole Sodium API Revenue by Company (2021-2026)
6.4.2 Japan Metamizole Sodium API Sales Breakdown by Type (2021-2026)
6.4.3 Japan Metamizole Sodium API Sales Breakdown by Application (2021-2026)
6.4.4 Japan Metamizole Sodium API Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Arcadia Lifescience
7.1.1 Arcadia Lifescience Company Information
7.1.2 Arcadia Lifescience Business Overview
7.1.3 Arcadia Lifescience Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Arcadia Lifescience Metamizole Sodium API Products Offered
7.1.5 Arcadia Lifescience Recent Development
7.2 Hengdian Group
7.2.1 Hengdian Group Company Information
7.2.2 Hengdian Group Business Overview
7.2.3 Hengdian Group Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Hengdian Group Metamizole Sodium API Products Offered
7.2.5 Hengdian Group Recent Development
7.3 Shandong Xinhua Pharmaceutical
7.3.1 Shandong Xinhua Pharmaceutical Company Information
7.3.2 Shandong Xinhua Pharmaceutical Business Overview
7.3.3 Shandong Xinhua Pharmaceutical Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Shandong Xinhua Pharmaceutical Metamizole Sodium API Products Offered
7.3.5 Shandong Xinhua Pharmaceutical Recent Development
7.4 Wuhan Wuyao Pharmaceutical
7.4.1 Wuhan Wuyao Pharmaceutical Company Information
7.4.2 Wuhan Wuyao Pharmaceutical Business Overview
7.4.3 Wuhan Wuyao Pharmaceutical Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Wuhan Wuyao Pharmaceutical Metamizole Sodium API Products Offered
7.4.5 Wuhan Wuyao Pharmaceutical Recent Development
7.5 Astitva Chemicals
7.5.1 Astitva Chemicals Company Information
7.5.2 Astitva Chemicals Business Overview
7.5.3 Astitva Chemicals Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Astitva Chemicals Metamizole Sodium API Products Offered
7.5.5 Astitva Chemicals Recent Development
7.6 Chemcopia
7.6.1 Chemcopia Company Information
7.6.2 Chemcopia Business Overview
7.6.3 Chemcopia Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Chemcopia Metamizole Sodium API Products Offered
7.6.5 Chemcopia Recent Development
7.7 Safic-Alcan
7.7.1 Safic-Alcan Company Information
7.7.2 Safic-Alcan Business Overview
7.7.3 Safic-Alcan Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Safic-Alcan Metamizole Sodium API Products Offered
7.7.5 Safic-Alcan Recent Development
7.8 Naarini Molbio Pharma
7.8.1 Naarini Molbio Pharma Company Information
7.8.2 Naarini Molbio Pharma Business Overview
7.8.3 Naarini Molbio Pharma Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Naarini Molbio Pharma Metamizole Sodium API Products Offered
7.8.5 Naarini Molbio Pharma Recent Development
7.9 Conscientia Industrial
7.9.1 Conscientia Industrial Company Information
7.9.2 Conscientia Industrial Business Overview
7.9.3 Conscientia Industrial Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Conscientia Industrial Metamizole Sodium API Products Offered
7.9.5 Conscientia Industrial Recent Development
7.10 Pipelinepharma
7.10.1 Pipelinepharma Company Information
7.10.2 Pipelinepharma Business Overview
7.10.3 Pipelinepharma Metamizole Sodium API Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Pipelinepharma Metamizole Sodium API Products Offered
7.10.5 Pipelinepharma Recent Development
8 Metamizole Sodium API Manufacturing Cost Analysis
8.1 Metamizole Sodium API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Metamizole Sodium API
8.4 Metamizole Sodium API Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Metamizole Sodium API Distributors List
9.3 Metamizole Sodium API Customers
10 Metamizole Sodium API Market Dynamics
10.1 Metamizole Sodium API Industry Trends
10.2 Metamizole Sodium API Market Drivers
10.3 Metamizole Sodium API Market Challenges
10.4 Metamizole Sodium API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Metamizole Sodium API market is projected to grow from US$ 395 million in 2025 to US$ 504 million by 2032, at a CAGR of 3.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 144
USD 4900.00
(Single User License)
The global Metamizole Sodium API market was valued at US$ 395 million in 2025 and is anticipated to reach US$ 504 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 135
USD 2900.00
(Single User License)
The global market for Metamizole Sodium API was estimated to be worth US$ 395 million in 2025 and is projected to reach US$ 504 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 96
USD 3950.00
(Single User License)
Valued at US$ 395 million in 2024, the global Metamizole Sodium API market is forecast to reach US$ 489 million by 2030, at a CAGR of 3.6% during the forecast period.
Published Date: 2025-02-28
Pages: 137
USD 4900.00
(Single User License)
The global Metamizole Sodium API market size was US$ 379 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-02-28
Pages: 79
USD 4250.00
(Single User License)
The global market for Metamizole Sodium API was valued at US$ 379 million in the year 2024 and is projected to reach a revised size of US$ 489 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published Date: 2025-02-28
Pages: 93
USD 2900.00
(Single User License)
The global market for Metamizole Sodium API was estimated to be worth US$ 379 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-02-28
Pages: 91
USD 3950.00
(Single User License)
The global Metamizole Sodium API market is projected to grow from US$ 395 million in 2025 to US$ 504 million by 2032, at a CAGR of 3.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 144
The global Metamizole Sodium API market was valued at US$ 395 million in 2025 and is anticipated to reach US$ 504 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-03-11
Pages: 135
The global market for Metamizole Sodium API was estimated to be worth US$ 395 million in 2025 and is projected to reach US$ 504 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-03-08
Pages: 96
Valued at US$ 395 million in 2024, the global Metamizole Sodium API market is forecast to reach US$ 489 million by 2030, at a CAGR of 3.6% during the forecast period.
Published: 2025-02-28
Pages: 137
The global Metamizole Sodium API market size was US$ 379 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-02-28
Pages: 79
The global market for Metamizole Sodium API was valued at US$ 379 million in the year 2024 and is projected to reach a revised size of US$ 489 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-02-28
Pages: 93
The global market for Metamizole Sodium API was estimated to be worth US$ 379 million in 2024 and is forecast to a readjusted size of US$ 489 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-02-28
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now